{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:48:28Z","timestamp":1783579708553,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["311790"],"award-info":[{"award-number":["311790"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clim.2021.108818","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:19:17Z","timestamp":1628047157000},"page":"108818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine"],"prefix":"10.1016","volume":"230","author":[{"given":"Miguel","family":"Garc\u00eda-Grimshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaclara","family":"Michel-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Mauricio","family":"Vera-Zertuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Andr\u00e9s","family":"Galnares-Olalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Hern\u00e1ndez-Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Figueroa-Cucurachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Paredes-Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Carbajal-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santa Elizabeth","family":"Ceballos-Liceaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Iv\u00e1n","family":"Vald\u00e9s-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108818_bb0005","first-page":"1","article-title":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108818_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108818_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring \u2014 United States","volume":"70","author":"Gee","year":"2021","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clim.2021.108818_bb0020","article-title":"COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (oceans) II","author":"Freeman","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.clim.2021.108818_bb0025","first-page":"1","article-title":"Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake","author":"Nguyen","year":"2021","journal-title":"MedRxiv Prepr. Serv. Heal. Sci."},{"key":"10.1016\/j.clim.2021.108818_bb0030","first-page":"n18","article-title":"COVID-19 in 2021\u2014continuing uncertainty","volume":"372","author":"del Rio","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.clim.2021.108818_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell\u2019s palsy and SARS-CoV-2 vaccines","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.clim.2021.108818_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2020.00361","article-title":"Do vaccines have a role as a cause of autoimmune neurological syndromes?","volume":"8","author":"Principi","year":"2020","journal-title":"Front. Public Health"},{"key":"10.1016\/j.clim.2021.108818_bb0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2021.108818_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2021.108818_bb0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.clim.2021.108818_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide: a systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.clim.2021.108818_bb0065","series-title":"Diagn\u00f3stico y Manejo del S\u00edndrome de Guillain Barr\u00e9 en la Etapa Aguda, en el Primer Nivel de Atenci\u00f3n","first-page":"1","author":"Secretar\u00eda de Salud; Gobierno de M\u00e9xico","year":"2010"},{"key":"10.1016\/j.clim.2021.108818_bb0070","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.1016\/j.clim.2021.108786","article-title":"Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108818_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.clim.2021.108818_bb0080","author":"S. S. de Gobierno de M\u00e9xico"},{"key":"10.1016\/j.clim.2021.108818_bb0085","first-page":"2020","article-title":"Unclear association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"2021","author":"Vogrig","year":"2020","journal-title":"Brain."},{"key":"10.1016\/j.clim.2021.108818_bb0090","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/acn3.50946","article-title":"Antecedent infections in Guillain-Barr\u00e9 syndrome: a single-center, prospective study","volume":"6","author":"Hao","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2021.108818_bb0095","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1371\/journal.pone.0067185","article-title":"Guillain-Barr\u00e9 syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-Centered analysis in the vaccine safety datalink, 2009-2011","volume":"8","author":"Greene","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2021.108818_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:03Z","timestamp":1761494643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":20,"alternative-id":["S1521661621001558"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108818","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108818"}}